In a very disappointing ruling for those who want to punish drug cheats in boxing, the WBO has ruled that its middleweight champion, Zhanibek Alimkhanuly, can keep his title despite testing positive for the banned substance meldonium. Instead of striping the boxer, as was expected, the WBO imposed a one-year suspension and a series of conditions that stop short of stripping Alimkhnauly of the championship. The decision follows positive “A” and “B” sample tests collected by the Voluntary Anti-Doping Association (VADA) in November 2025, which forced Alimkhanuly out of a scheduled unification bout against Erislandy Lara in December. Although not a party to this ruling, the IBF is just as culpable, as it also continues to recognize Alimhanuly as its world middleweight champion. An interim title fight between Denzel Bentley and Endry Saavedra was ordered to keep the division active during his suspension.
In a lengthy written decision issued by its World Championship Committee, the WBO confirmed that the tests were conducted by recognized anti-doping authorities and verified by a WADA-accredited laboratory, leaving no dispute about the presence of the prohibited substance. Under the organization’s rules, the case fell under a “strict liability” standard, meaning intent or explanation was irrelevant once a positive test was confirmed. Despite that framework, the WBO declined to impose its most severe sanction — vacating Alimkhanuly's title — and instead opted for what it described as a “proportionate” response.
The ruling suspends Alimkhanuly for one year, retroactive to December 2nd, the date of official notification of the adverse test. He is also required to submit to year-round random drug testing under a WADA-certified program at his own expense, complete an anti-doping education course, and provide certified test results directly to the WBO. When the suspension ends, he will not be allowed a tune-up fight; his first bout must be against either the WBO interim champion or the organization’s mandatory challenger.
The WBO framed the outcome as balanced and fair. Others will see it differently — as a decision that does not meaningfully penalize a fighter who failed a drug test, and does little to deter future violations at the highest level of the sport.
So what is the end result? Alimkhanuly remains recognized as a two-belt champion, retains his title status, and faces no financial penalty. The suspension is time-limited, a year in name but effectively only ten months, and the conditions imposed largely amount to monitoring and compliance requirements rather than punitive measures. For a confirmed doping violation that canceled a major unification bout and disrupted the middleweight division, the consequences are relatively light.
The committee justified its approach by citing Alimkhanuly’s status as a first-time offender and the absence of prior anti-doping violations. It emphasized proportionality and the legal and commercial interests tied to championship recognition. In effect, the WBO treated the case as a regulatory issue to be managed rather than a breach warranting the strongest available punishment. For critics, that distinction matters. A positive test for a banned substance typically carries the expectation of severe sporting consequences, especially for a reigning world champion. By allowing Alimkhanuly to keep his title and return after a defined suspension, the ruling sends a message that a confirmed drug violation does not necessarily lead to the loss of a championship. It should be noted that Alimkhanuly tested positive for meldonium, which is clearly banned in international competitions but is legally available for purchase in Kazakhstan, Russia and a few other countries.
PRIOR BOXINGTALK COVERAGE
DEC. 5, 2025: After a positive test for the banned substance meldonium, the WBO World Championship Committee has issued a “show cause notice” to WBO / IBF middleweight champion Zhanibek Alimkhanuly. The notice stated, "It has been formally reported that on December 2nd, the WBO received an official communication from the Voluntary Anti-Doping Agency (VADA) concerning an alleged anti-doping violation arising from the testing protocol enforced by said agency in preparation for the scheduled WBO/IBF unified middleweight championships contest against [WBA champion] Erislandy Lara to be held in San Antonio, Texas on December 6th.According to the notice, the “A” Sample of [Alimkhanuly's] urine specimen, collected on November 15th, in Porter Ranch, California, allegedly returned an adverse analytical finding for a banned substance at an estimated concentration greater than the minimum reported threshold.
Unlike the WBC, which lately has been giving virtually no penalties to boxers who test positive for banned substances [Conor Benn and Subriel Matias come to mind], WBO policy is that "in the event any WBO champion tests positive for any banned substances, the WBO doesn’t need to demonstrate intent, fault, negligence, or knowing use on the fighter’s part. It is the fighter’s duty to ensure that no prohibited substances enter their body. Fighters are fully responsible for any prohibited substances found to be present in their body."
Alimkhanuly was directed by the WBO to show cause within ten days of issuance of this notice, stating why disciplinary action should not be imposed pursuant to the applicable sections in the governing WBO Regulations of World Championship Contests and all relevant WBO policies; including but not limited to: a) declaring the WBO middleweight championship “vacant”; b) withdrawing WBO world champion status from Alimkhanuly; c) banning him from all WBO world and/or regional championship contests; d) suspending him sion from al WBO world and/or regional championship contests; and e) issuing any other rulings necessary, helpful or convenient to accomplish the purposes, policies and intent of the WBO.
Alimkhanuly's response may include supporting documentation, statements, legal submissions, or any other relevant materials he wishes the WBO to consider. Failure to respond within the prescribed period may result in disciplinary action being taken without further notice and/or hearing, including but not limited to the vacating of your WBO Championship title, effective immediately.
DEC. 3, 2025: WBA middleweight champion Erislandy “The American Dream” Lara will defend his title against hard-hitting challenger Johan Gonzalez as part of a four-fight PBC pay-per-view event on Prime Video this Saturday, December 6th from Frost Bank Center in San Antonio, Texas. Lara was originally scheduled to face unified champion Janibek Alimkhanuly, who was pulled from the fight after failing a VADA anti-doping test. The Lara vs. Gonzalez fight will follow the pay-per-view opener between Jesus “Mono” Ramos Jr. and Shane Mosley Jr. for the WBC interim middleweight title beginning at 8 p.m. ET/5 p.m. PT. The pay-per-view is headlined by former 140-pound title holder Isaac “Pitbull” Cruz taking on reigning WBA 130-pound champion Lamont Roach for the WBC interim title at 140 pounds. The showdown between two-division champion Stephen Fulton Jr. and WBC 130-pound champion O’Shaquie Foster will now serve as the co-feature. Tickets for the live event are on sale now through Ticketmaster.com.
DEC. 2, 2025: Janibek Alimkhanuly, the two-belt middleweight champion, has tested positive for a banned performance-enhancing substance just days before a scheduled unification fight against WBA middleweight champion Erislandy Lara. Journalist Dan Rafael reported that the substance was meldonium, which is commonly used in Russia. Alimkhanuly, from Kazakhstan, holds the WBO and IBF titles. He reacted to this development by tweeting, "I have always supported clean sport you know this well. I was surprised when I read the news. VADA took the first test and said everything was clean. I have not made any changes to my vitamins. I don’t know what happened with the second test, so I requested a retest." Alimkhanuly vs. Lara, which was scheduled for this Saturday, December 6th in San Antonio, Texas. The WBO acknowledged the positive test as follows: "The WBO has confirmed an adverse analytical finding for WBO middleweight champion Zhanibek Alimkhanuly from VADA testing ahead of his scheduled bout vs. Erislandy Lara. An internal investigation is now underway, and a show cause notice will be issued. No further comments will be made until the process is complete.
The World Boxing Organization has ruled that WBO middleweight champion Zhanibek Alimkhanuly will keep his title despite twice testing positive for the banned substance meldonium, imposing a one-year suspension and a series of conditions that stop short of stripping him of the championship. The decision follows positive “A” and “B” samples collected under the Voluntary Anti-Doping Association (VADA) program in November 2025, which forced Alimkhanuly out of a scheduled WBA/WBO unification bout against Erislandy Lara in December.
In a lengthy resolution issued by its World Championship Committee, the WBO confirmed that the tests were conducted by recognized anti-doping authorities and verified by a WADA-accredited laboratory, leaving no dispute about the presence of the prohibited substance. Under the organization’s rules, the case fell under a “strict liability” standard, meaning intent or explanation was irrelevant once a positive test was confirmed. Despite that framework, the WBO declined to impose its most severe sanction — vacating the WBO Middleweight Championship — and instead opted for what it described as a “proportionate” response.
The ruling suspends Alimkhanuly for one year, retroactive to December 2, 2025, the date of official notification of the adverse test. He is also required to submit to year-round random drug testing under a WADA-certified program at his own expense, complete an anti-doping education course, and provide certified test results directly to the WBO. When the suspension ends, he will not be allowed a tune-up fight; his first bout must be against either the WBO interim champion or the organization’s mandatory challenger. An interim title fight between Denzel Bentley and Endry Saavedra was ordered to keep the division active during his suspension.
While the ruling is detailed and procedural, the practical impact is limited. Alimkhanuly remains recognized as champion, retains his title status, and faces no financial penalty, fine, or vacating of the belt. The suspension is time-limited, and the conditions imposed largely amount to monitoring and compliance requirements rather than punitive measures. For a confirmed doping violation that canceled a major unification bout and disrupted the middleweight division, the consequences are relatively light.
The committee justified its approach by citing Alimkhanuly’s status as a first-time offender and the absence of prior anti-doping violations. It emphasized proportionality and the legal and commercial interests tied to championship recognition. In effect, the WBO treated the case as a regulatory issue to be managed rather than a breach warranting the strongest available punishment.
For critics, that distinction matters. A positive test for a banned substance typically carries the expectation of severe sporting consequences, especially for a reigning world champion. By allowing Alimkhanuly to keep his title and return after a defined suspension, the ruling sends a message that a confirmed drug violation does not necessarily lead to the loss of a championship.
The WBO framed the outcome as balanced and fair. Others will see it differently — as a decision that, while procedurally careful, does not meaningfully penalize a fighter who failed a drug test, and does little to deter future violations at the highest level of the sport.
PRIOR BOXINGTALK COVERAGE
DEC. 5, 2025: After a positive test for the banned substance meldonium, the WBO World Championship Committee has issued a “show cause notice” to WBO / IBF middleweight champion Zhanibek Alimkhanuly. The notice stated, "It has been formally reported that on December 2nd, the WBO received an official communication from the Voluntary Anti-Doping Agency (VADA) concerning an alleged anti-doping violation arising from the testing protocol enforced by said agency in preparation for the scheduled WBO/IBF unified middleweight championships contest against [WBA champion] Erislandy Lara to be held in San Antonio, Texas on December 6th.According to the notice, the “A” Sample of [Alimkhanuly's] urine specimen, collected on November 15th, in Porter Ranch, California, allegedly returned an adverse analytical finding for a banned substance at an estimated concentration greater than the minimum reported threshold.
Unlike the WBC, which lately has been giving virtually no penalties to boxers who test positive for banned substances [Conor Benn and Subriel Matias come to mind], WBO policy is that "in the event any WBO champion tests positive for any banned substances, the WBO doesn’t need to demonstrate intent, fault, negligence, or knowing use on the fighter’s part. It is the fighter’s duty to ensure that no prohibited substances enter their body. Fighters are fully responsible for any prohibited substances found to be present in their body."
Alimkhanuly was directed by the WBO to show cause within ten days of issuance of this notice, stating why disciplinary action should not be imposed pursuant to the applicable sections in the governing WBO Regulations of World Championship Contests and all relevant WBO policies; including but not limited to: a) declaring the WBO middleweight championship “vacant”; b) withdrawing WBO world champion status from Alimkhanuly; c) banning him from all WBO world and/or regional championship contests; d) suspending him sion from al WBO world and/or regional championship contests; and e) issuing any other rulings necessary, helpful or convenient to accomplish the purposes, policies and intent of the WBO.
Alimkhanuly's response may include supporting documentation, statements, legal submissions, or any other relevant materials he wishes the WBO to consider. Failure to respond within the prescribed period may result in disciplinary action being taken without further notice and/or hearing, including but not limited to the vacating of your WBO Championship title, effective immediately.
DEC. 3, 2025: WBA middleweight champion Erislandy “The American Dream” Lara will defend his title against hard-hitting challenger Johan Gonzalez as part of a four-fight PBC pay-per-view event on Prime Video this Saturday, December 6th from Frost Bank Center in San Antonio, Texas. Lara was originally scheduled to face unified champion Janibek Alimkhanuly, who was pulled from the fight after failing a VADA anti-doping test. The Lara vs. Gonzalez fight will follow the pay-per-view opener between Jesus “Mono” Ramos Jr. and Shane Mosley Jr. for the WBC interim middleweight title beginning at 8 p.m. ET/5 p.m. PT. The pay-per-view is headlined by former 140-pound title holder Isaac “Pitbull” Cruz taking on reigning WBA 130-pound champion Lamont Roach for the WBC interim title at 140 pounds. The showdown between two-division champion Stephen Fulton Jr. and WBC 130-pound champion O’Shaquie Foster will now serve as the co-feature. Tickets for the live event are on sale now through Ticketmaster.com.
DEC. 2, 2025: Janibek Alimkhanuly, the two-belt middleweight champion, has tested positive for a banned performance-enhancing substance just days before a scheduled unification fight against WBA middleweight champion Erislandy Lara. Journalist Dan Rafael reported that the substance was meldonium, which is commonly used in Russia. Alimkhanuly, from Kazakhstan, holds the WBO and IBF titles. He reacted to this development by tweeting, "I have always supported clean sport you know this well. I was surprised when I read the news. VADA took the first test and said everything was clean. I have not made any changes to my vitamins. I don’t know what happened with the second test, so I requested a retest." Alimkhanuly vs. Lara, which was scheduled for this Saturday, December 6th in San Antonio, Texas. The WBO acknowledged the positive test as follows: "The WBO has confirmed an adverse analytical finding for WBO middleweight champion Zhanibek Alimkhanuly from VADA testing ahead of his scheduled bout vs. Erislandy Lara. An internal investigation is now underway, and a show cause notice will be issued. No further comments will be made until the process is complete.
